Battelle Memorial Institute

Battelle Memorial Institute, a large Columbus, Ohio-headquartered nonprofit research and development organization, operates as a prime contractor on over 15,900 federal awards spanning defense, health, environmental, energy, and scientific domains, with a $337.73 billion combined potential value and minimal set-aside participation—competing predominantly through full and open procurements rather than 8(a), HUBZone, or small-business vehicles.

Battelle's customer concentration is heavily weighted toward Department of Defense entities. The top five funding agencies by count—the Department of the Army, Department of the Air Force, the Army Materiel Command Research Development and Engineering Command, the Army Materiel Command Army Contracting Command Aberdeen Proving Ground, and the Defense Logistics Agency—represent 51% of awards but only about 22% of combined potential value by the source's coverage metric. The divergence reflects Battelle's depth with Army logistics and acquisition infrastructure contracts (low individual value, high volume) versus concentrated large-value exposure to the Office of the Secretary of Defense ($111.49 billion) and the Army's materiel command offices ($38.44 billion and $14.72 billion respectively). Battelle functions nearly entirely as a prime (99% of awards) rather than as a subcontractor (1%), signaling it builds its own delivery teams rather than feeding as a sub to larger integrators. Across SCI-reportable prime contracts in fiscal years 2022–2024, the vendor deployed approximately 197–234 FTEs annually and invoiced $249 million total, with median government-paid rates around $143/hour, ranging from entry-level internship roles at $37/hour through senior technical director positions at $433/hour. Subcontractors account for roughly 8% of hours across SCI prime records, with 218 named subs reported; Battelle's subcontractor footprint includes Ch2M Hill (environmental remediation and PFAS testing), Assured Information Security (Air Force cyber and systems engineering), Lockheed Martin (vehicle components), and specialized analytical and component suppliers, reflecting Battelle's role as a systems integrator rather than a pure lab services vendor.

Battelle's concrete federal capability portfolio centers on R&D, environmental and chemical testing, preclinical animal models and infectious disease research, armored vehicle procurement and modification, information systems development, air quality monitoring, and specialized defense engineering. Representative prime awards include a $93.3 million Defense Threat Reduction Agency contract for international biological threat reduction (awarded January 2026, cost-plus-fixed-fee through January 2031); a $125 million Marine Corps delivery order for chemical, biological, radiological, and nuclear defense testing and sustainment (September 2024–September 2029, cost-plus-fixed-fee); a $45.6 million Army Combat Capabilities Development Command delivery order for force projection technology research and laboratory planning (October 2025–September 2030, cost-plus-fixed-fee, performed in Warren, Michigan); a $42.6 million Joint PEO Chemical and Biological Defense order for soldier protection engineering and analysis (January 2025–January 2030, cost-plus-fixed-fee, at Natick, Massachusetts); and a $37.8 million Air Force Life Cycle Management Center delivery order for C-130J Electronic Modular Aerial Spray System development and sustainment (March 2025–January 2028). Battelle also holds significant work in environmental compliance and testing: a $90 million EPA Office of Research and Development single-award STREAMS V contract (January 2026–January 2033) for pollution prevention and ecosystem restoration support; multiple EPA air quality and ambient air monitoring BPA calls under the GSA Multiple Award Schedule; and U.S. Army Corps of Engineers contracts for environmental peer review, sediment analysis, and remediation. In health and infectious disease, Battelle operates under $146.3 million NIAID Pre-Clinical Models of Infectious Diseases contract (July 2024–July 2031) and a $136.6 million NIAID Evaluation and Testing Services contract for vaccines and biologics (September 2025–September 2035), supporting preclinical drug candidate evaluation, animal model development, and vaccine testing; recent task orders include $4.8 million for mpox antiviral evaluation (September 2025) and $22.9 million for ferret model refinement for improved influenza vaccines (September 2025–September 2030). Vehicle procurement and modification work includes ongoing orders with U.S. Special Operations Command and the Air Force for specialized armored vehicle procurement and integration, totaling tens of millions of dollars annually for OEM Hilux, TLC76, TLC79, and TLC300 platforms with integrated communications, armor, and suspension systems; subcontractors include Underground Pipeline Inc., L3Harris Technologies, Raka Corporation, and Isoclima Specialty Glass for components. Battelle also delivers research and engineering services across DARPA (including $8.71 million Project Istanbul, December 2024–June 2027, and $10.3 million Microsystems Induced Catalysis, August 2025–October 2028, cost-plus-fixed-fee), Strategic Systems Programs (Trident II D-5 ballistic missile engineering support, $10.6 million over five option years), and civilian agencies including FDA food supply chain integrity work, DHS cargo screening support, and NSF ecological research infrastructure development.

Battelle's vehicle position spans the entire federal contracting landscape. On large government-wide IDIQs, Battelle holds a seat on the $999.999 billion OASIS+ Unrestricted Multiple Award Contract (GSA Federal Acquisition Service, December 2024–December 2029), through which it has received a $25.2 million Air Force delivery order for robotic and autonomous systems technologies (April 2026). Battelle also holds a $151 billion Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) contract with the Missile Defense Agency (December 2025–December 2035) and a $25.357 billion Advanced Technology Support Program V (ATSP V) seat with the Defense Microelectronics Activity (April 2026–December 2035). On specialized defense IDIQs, Battelle operates under a $52.9 million C-130J Electronic Modular Aerial Spray System contract (Air Force, March 2025–March 2030), a $350 million non-standard commercial vehicle contract with U.S. Special Operations Command, a $42.6 million Information Analysis Center Multiple-Award Contract (IAC-MAC) seat with the Joint PEO Chemical and Biological Defense, and a $1.77 million Scientific, Technical, Engineering and Program Support Services (STEPSS) Army vehicle for chemical warfare agent research. On health and research vehicles, Battelle holds the $146.3 million Pre-Clinical Models of Infectious Diseases IDC (NIAID, July 2024–July 2031) and a $136.6 million Evaluation and Testing Services contract (NIAID, September 2025–September 2035) for vaccine and biologics testing. On civilian agency vehicles, Battelle maintains an $90 million STREAMS V single-award contract with EPA (January 2026–January 2033), a $120 million Human Factors IDIQ with the National Highway Traffic Safety Administration (September 2024–March 2030), a $10.1 million FAA Airport Rescue and Fire Fighting research vehicle (September 2025–September 2030), and a $3 million NIST AI assessment services basic ordering agreement (August 2025–August 2026). Environmental and federal highway vehicles include GSA Multiple Award Schedule BPAs for ambient air and quality assurance support (68HERD21A0001), and additional FHWA BPA calls for Transportation Management System device placement and policy support. This breadth of vehicle access positions Battelle as a capable prime across task-order-based procurement for federal agencies across defense, civilian, and health domains.

Recent activity shows modest year-over-year decline: 2024 peaked at 163 awards, dropping to 155 in 2025 and 46 by mid-2026 (limited by mid-year cutoff). Within the next twenty-four months, 149 awards with combined potential value of $1.39 billion face ultimate completion and therefore recompete exposure. Battelle's federal footprint remains concentrated in large research, development, test, and evaluation (6,471 PSC R&D–classified awards) and environmental support (698 awards) work under cost-plus-fixed-fee and time-and-materials structures, reflecting the nonprofit research organization model and the nature of federal R&D contracting. The vendor's corporate structure includes 23 named subsidiaries spanning for-profit entities (Seebyte Inc., Battelle Nuclear Solutions Inc.) and nonprofit affiliates (Battelle Energy Alliance, LLC, Omniviz Inc.), though the source does not detail subsidiary-level contract activity or ownership relationships beyond the parent corporate entity designation.